Regulation 2, National Medical Commission (Appeals of Importers of drugs) Regulations, 2026 [SB3-XPS]

As at 7 September 2026. In force from 4 March 2026.

In National Medical Commission (Appeals of Importers of drugs) Regulations, 2026 [R1G-YFT]. This text from 4 March 2026. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Regulation 2, National Medical Commission (Appeals of Importers of drugs) Regulations, 2026 [SB3-XPS]. Machine: SB3-XPS.

Definitions.—In these regulations, unless the context otherwise requires,— (a) "Act" means the National Medical Commission Act, 2019 (30 of 2019); (b) "importer of drugs" means a person carrying on the import of drugs; (c) "batch" means a batch received, held or disposed of by a importer of drugs in the course of the import of drugs; (d) "Form 21" means the form so numbered in the Schedule; (e) words and expressions used herein and not defined but defined in the Act shall have the meanings respectively assigned to them in the Act.

Defined terms in this text (0)

none

Made under this regulation, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this regulation (0)

none